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ABSTRACT
Glioma stem cells (GSCs) play an important role in glioblastoma prognosis. 
Exosomes (EXs) mediate cell communication by delivering microRNAs (miRs). 
Glioblastoma has a high level of miR-21 which could upregulate vascular endothelial 
growth factor (VEGF) expression. We hypothesized GSC-EXs can promote the 
angiogenic ability of endothelial cells (ECs) through miR-21/VEGF signal. GSCs were 
isolated from U-251 cells with stem cell marker CD133. GSCs transfected without 
or with scramble or miR-21 mimics were used to produce GSC-EXscon, GSC-EXssc 
and GSC-EXsmiR-21. Human brain ECs were co-cultured with vehicle, GSC-EXscon, GSC-
EXssc or GSC-EXsmiR-21 plus VEGF siRNAs (siRNAVEGF). After 24 hours, the angiogenic 
abilities of ECs were evaluated. The levels of miR-21, VEGF and p-Flk1/VEGFR2 were 
determined. Results showed: 1) Over 90% of purified GSCs expressed CD133; 2) 
The levels of miR-21 and VEGF in GSCs  and GSC-EXs were up-regulated by miR-21 
mimic transfection; 3) Compared to GSC-EXscon or GSC-EXssc, GSC-EXsmiR-21 were more 
effective in elevating the levels of miR-21 and VEGF, and the ratio of p-Flk1/VEGFR2 
in ECs; 4) GSC-EXsmiR-21 were more effective in promoting the angiogenic ability 
of ECs than GSC-EXscon or GSC-EXssc, which were remarkably reduced by siRNAVEGF 
pretreatment. In conclusion, GSC-EXs can promote the angiogenic ability of ECs by 
stimulating miR-21/VEGF/VEGFR2 signal pathway.
INTRODUCTION 
Glioblastoma is the most common and malignant 
brain tumor in adults. Current therapies for glioblastoma 
include surgical resection, radiotherapy and chemotherapy. 
However, the five-year survival rate for glioblastoma is 
less than 5%, and its median survival period is only 14.6 
months in adults [1]. The ineffectiveness of the treatments 
majorly result from the tumor cellular heterogeneity, the 
high migratory capability of glioblastoma and chemo-
resistance [2]. 
Cancer stem cells have been suggested to participate 
in tumor growth and radio- or chemo- resistance [3, 4]. 
Glioma stem cells (GSCs) are multipotent tumor-initiating 
cells which display stem cell properties [5, 6] and express 
CD133 marker [7, 8]. Increasing evidence suggests that 
the aggressiveness and unresponsiveness of glioblastoma 
might be related to the presence of GSCs [9, 10]. Indeed, 
GSCs can promote tumor angiogenesis [11] and have been 
shown to be resistant to cell death following growth factors 
withdrawal [12, 13]. Thus, understanding the mechanism 
of how GSCs promote metastasis of glioblastoma will be 
important for developing efficient therapeutic strategies. 
Angiogenesis and extensive invasion are hallmark 
features of malignant glioblastoma. As we know, 
cancer cells can subvert surrounding normal cells such 
as endothelial cells (ECs) to promote tumor growth, 
angiogenesis and metastases [14, 15]. Currently, 
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extracellular exosomes (EXs) are emerging as novel 
intercellular communicators. Mounting evidence has 
shown that EXs can convey cargoes such as proteins and 
microRNAs (miRs) to distant/nearby cells and modulate 
recipient cell function [16–18]. Exosomal miR-135b 
from hypoxia-resistent multiple myeloma cells could 
enhance endothelial tube formation under hypoxia [19]. 
The extracellular vesicles released from glioblastoma cells 
have been shown to transfer RNAs to brain microglia/
macrophages [20], suggesting the potential of glioblastoma 
in manipulating its environment. Nevertheless, no study 
has investigated the potential role of GSC-derived EXs 
(GSC-EXs) on EC functions. 
As an oncomiR, miR-21 is expressed in a wide range 
of cancers. It promotes cell proliferation and migration [2]. 
Earlier studies have identified that vascular endothelial 
growth factor (VEGF) plays a key role in the angiogenesis 
process of astrocytoma [21, 22]. Overexpressing miR-21 
increased the expression of VEGF in a prostate cell line 
and induced tumor angiogenesis [23]. Downregulation 
of miR-21 in glioblastoma cells caused repression 
of cell growth which theoretically could enhance the 
chemotherapeutic effects of cancer therapy [24]. Recently, 
another study revealed that GSCs can produce higher 
levels of VEGF and contribute to tumor angiogenesis [11]. 
However, whether EXs-derived from GSCs (GSC-EXs) 
can promote the angiogenesis through their carried miRs 
and proteins remains unknown.
In this study, we aimed to investigate whether GSC-
EXs can promote the angiogenic function of ECs through 
the miR-21/VEGF signal.  
RESULTS
Purification of GSCs from U251 cells
The cell surface antigen CD133 is considered 
as a marker of stem cells. Indeed, several studies have 
demonstrated CD133 can be used to isolate a population 
of cells with stem-cell properties [25, 26]. Here, we used 
anti-CD133 conjugated beads to isolate GSCs from U251 
cells. The purification efficiency was assessed by flow 
cytometry. The data (Figure 1) showed that anti-CD133-
conjugated beads enriched CD133+ cells to 90 ± 6% from 
U-251 cells (25 ± 5%). 
MiR-21 overexpression increased VEGF mRNA 
level in GSCs 
The success of miR-21 mimic or inhibitor 
transfection was confirmed by qRT-PCR. As shown in 
Figure 2A, the level of miR-21 in GSCs was remarkably 
up-regulated by miR-21 mimics. There was no significant 
difference of the miR-21 level between GSCs in control 
(GSCscon) and those transfected with scramble control 
(GSCssc). In addition, we found that miR-21 mimics 
elevated the mRNA level of VEGF in GSCs as compared 
to that in GSCscon or GSCssc (Figure 2B).
GSC-EXsmiR-21 harbored high levels of miR-21 
and VEGF 
It is believed that EXs can carry the cargoes such 
as miRs and proteins from their parent cells. We focused 
on determining the level of miR-21 and VEGF in GSC-
EXs. First of all, we analyzed the size and concentration 
of GSC-EXs and assessed the expression of EX specific 
marker CD63 by using NTA. As shown in Figure 3A–
3B, the three types of GSC-EXs displayed a similar size 
distribution. The average size was approximately 20-120 
nm. There was no difference of the concentration of EXs 
in the three groups.  According to the fluorescence NTA 
results, over 90% of EXs expressed CD63 (Figure 3C).
Next, we examined the levels of miR-21 and VEGF 
in GSC-EXs. We found that the EXs-derived from GSCs 
transfected with miR-21 mimics (GSC-EXsmiR-21) carried 
a higher level of miR-21 and VEGF as compared to that 
in the EXs-derived from control GSCs (GSC-EXscon) or 
the EXs-derived from GSCs transfected with scramble 
control (sc) of miR-21 (GSC-EXssc) (Figure 3D–3E). 
Altogether, the levels of miR-21 and VEGF in GSC-
EXsmiR-21 appeared to be paralleled with their parent cells, 
GSCsmiR-21. 
GSC-EXsmiR-21 had better effects on elevating 
miR-21 level and VEGF secretion of ECs than 
GSC-EXscon 
Increasing evidence shows that EXs are crucial in 
cell-cell communication [16, 27]. To examine whether 
GSC-EXs could be up-taken by ECs, the GSC-EXs 
were labeled with red fluorescence PKH26 and added 
to the culture medium of ECs. As shown in Figure 4A, 
the labeled GSC-EXs were observed in the cytoplasm of 
ECs, suggesting that the GSC-EXs can be incorporated 
into ECs. Meanwhile, our data showed that there was no 
significant difference of the fluorescence intensity in ECs 
after GSC-EX co-culture, indicating that similar amounts 
of GSC-EXs were up-taken by ECs. 
Then, we assessed whether GSC-EXs can alter the 
levels of miR-21 and VEGF in the recipient cells, ECs. 
Our results (Figure 4B) showed that GSC-EXscon or GSC-
EXssc co-culture alone significantly increased the level 
of miR-21 in ECs, and this effect was further enhanced 
by GSC-EXsmiR-21. These data suggest that GSC-EXs can 
transfer miR-21 to ECs. Similarly, a higher concentration 
of VEGF was detected in the culture medium of ECs co-
cultured with GSC-EXsmiR-21 than those co-cultured with 
vehicle (culture medium only), GSC-EXscon or GSC-
EXssc (Figure 4C). All of these data show that GSC-
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Figure 1: MACS purification of GSCs from U-251 cells and characterization of GSCs by flow cytometry. GSCs were 
defined as CD133+ cells, which were separated by using MACS and assessed by flow cytometry for determining the efficiency of purification. 
(A) representative flow plots showing the percentage of CD133+ cells in U-251 cells and the purified GSCs; left curve: isotype control; right 
curve: antibody; (B) summarized data showing the percentage of CD133+ cells before and after MACS; *p < 0.05, vs. U-251 cells. Data are 
expressed as mean ± SEM; n = 3/group. MACS: magnetic activated cell sorting. 
Figure 2: Up-regulation of miR-21 by miR-21 mimic transfection increased VEGF mRNA expression in GSCs. The 
purified GSCs were transfected with miR-21 for 48 hrs, and the levels of miR-21 and VEGF were determined by qRT-PCR. (A–B) the 
levels of miR-21 and VEGF in different types of GSCs; *p < 0.05, vs. GSCscon or GSCssc; Data are expressed as mean ± SEM; n = 4/group. 
EXsmiR-21 can up-regulate the levels of miR-21 and VEGF 
in ECs.
GSC-EXsmiR-21 had better effect than GSC-EXscon 
on promoting the angiogenic ability of ECs 
To further investigate whether miR-21 is involved 
in promoting the tube formation and migration abilities of 
ECs, we treated ECs with GSC-EXsmiR-21 and its control, 
GSC-EXscon or GSC-EXssc or GSC-EXsmiR-21 ko. As shown 
in Figure 5, GSC-EXscon or GSC-EXssc alone enhanced the 
tube formation and migration abilities of ECs as compared 
to the vehicle (culture medium only). What’s more, the 
angiogenic ability of ECs was much greatly enhanced by 
GSC-EXsmiR-21. In addition, to determine whether VEGF 
is involved in the effect of GSC-EXs, we blocked VEGF 
with VEGF siRNA (siRNAVEGF) in ECs. Our data showed 
that siRNAVEGF remarkably reduced the angiogenic ability 
of ECs elicited by GSC-EXsmiR-21. Altogether, these data 
indicate that GSC-EXs increase the angiogenic ability of 
ECs through miR-21/VEGF.
GSC-EXs activated the VEGF/VEGFR2 
pathway in ECs
It is known that VEGFR2 is responsible for 
most downstream angiogenic effects of VEGF in 
tumors including migration, invasion, and endothelial 
proliferation. For assessing whether the GSC-EX co-
culture can activate the VEGF/VEGR2 signal, we 
measured the phosphorylation of VEGFR2 in ECs. Our 
data (Figure 6) showed that both GSC-EXscon and GSC-
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EXssc significantly raised the ratio of p-Flk/VEGFR2 in 
ECs, which was further enhanced by GSC-EXsmiR-21. 
DISCUSSION
The main findings of this study include that 1) 
GSC-EXs can promote the angiogenic ability of ECs; 
2) miR-21/VEGF/VEGFR2 signaling is the underlying 
mechanism of the effects elicited by GSC-EXs. 
Cancer stem cells participate in tumor growth and 
chemotherapy resistance [3, 4]. Increasing evidence 
suggests that the presence of GSCs could result in the 
aggressiveness of glioblastoma [9, 10], although the 
exact mechanism of how GSCs promote metastasis of 
Figure 3: Up-regulation of miR-21 in GSCs by miR-21 mimic transfection increased the levels of miR-21 and VEGF 
mRNA expression in GSC-EXsmiR-21. (A) representative NTA plots showing the same pattern of size distribution of the three types 
of GSC-EXs; (B) summarized data showing the concentration of EXs. (C) CD63 expression in the collected EXs. *p < 0.05, vs. GSCs; 
(D–E) summarized data showing the levels of miR-21 and VEGF in various types of GSC-EXs. *p < 0.05, vs. GSC-EXscon or GSC-EXssc; 
Data are expressed as mean ± SEM; n = 4/group. 
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glioblastoma is unclear. CD133 has been well recognized 
as a marker for GSCs [25, 26]. We successfully purified 
GSCs from U-251 cells by using CD133-conjugated 
beads, with the purity > 90% as confirmed by flow 
cytometry (Figure 1). 
In recent years, increasing evidence indicates that 
EXs function as intercellular messengers to facilitate 
cancer progression and metastasis [27, 28]. Indeed, tumor-
derived EXs have been shown to modify healthy cells 
by altering their translational profile to promote tumor 
progression [29]. Extracellular vesicles derived from 
glioblastoma cells could modify recipient cells (endothelial 
or monocytes) through transferring proteins and messenger 
RNAs and non-coding RNAs [16-18]. In the present study, 
we aimed to investigate whether GSC-EXs plays a role in 
promoting the angiogenic ability of ECs. Our data (Figure 
5) revealed that GSC-EXscon offered a promotion effect on 
tube formation and migration ability of ECs, supporting 
the notion that EXs released from malignant cells can 
affect the function of surrounding cells.
It is known that extensive angiogenesis and 
invasion are two typical features of glioblastoma. The 
pro-angiogenic role of miR-21 has been indicated in 
a previous study showing that knock-down of miR-21 
decreased neointimal hyperplasia following angioplasty 
[30]. Increasing evidence shows that the level of miR-
21 is significantly elevated in human cancers include 
glioblastoma and melanoma [31, 32]. It is known 
that miRs transferred via EXs could mediate cell-cell 
communication, however, whether GSC-EXs can transfer 
miR-21 to interfere the angiogenic ability of ECs remains 
unknown. In order to explore the role of miR-21 in 
angiogenic ability of ECs promoted by GSCs-EXs, we 
overexpressed miR-21 in GSCs to obtain miR-21 enriched 
EXs (GSC-EXsmiR-21). The miR-21 level in GSCs and 
the correspond EXs was verified by qRT-PCR. Our data 
showed that miR-21 level was elevated in GSC-EXsmiR-21, 
which paralleled with their parent cells, GSCsmiR-21 
(Figures 2 and 3), suggesting the success of transfection. 
Previous studies have revealed that VEGF is involved in 
EC recruitment, proliferation and vasculature formation 
to support the expansion of malignant tumors [33, 34]. In 
this study, we found that the mRNA level of VEGF was 
increased in GSC-EXsmiR-21 (Figure 2). This is in consistent 
with previous studies showing that miR-21 can enhance 
VEGF expression [23, 28].
In order to elucidate whether GSC-EXs co-culture 
can affect the miR-21 level and VEGF secretion of ECs, 
Figure 4: Incorporation of various GSC-EXs into ECs and GSC-EXsmiR-21 had better effects on increasing miR-21 
level and VEGF secretion of ECs. (A) left: representative images showing the incorporation of GSC-EXs into ECs; bar: 100 µm; 
red: PKH26 labeled GSC-EXs; blue: DAPI counterstained nucleus; right: summarized data showing the fluorescence intensity in ECs co-
cultured with the three types of GSC-EXs; (B) summarized data showing the level of miR-21 in ECs co-cultured with the three types of 
GSC-EXs; (C) summarized data showing the concentration of VEGF in the culture medium of ECs co-cultured with GSC-EXs. *p < 0.05, 
vs. vehicle; +p < 0.05, vs. GSC-EXscon or GSC-EXssc; Data are expressed as mean ± SEM; n = 4/group.
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Figure 5: GSC-EXsmiR-21 had better effects than GSC-EXscon and GSC-EXssc on promoting the angiogenic ability 
of ECs. (A) representative images and the summarized data showing the tube formation ability of ECs treated by various types of GSC-
EXs; bar: 500 µm; (B) summarized data showing the migration ability of ECs in different treatment groups. *p < 0.05, vs. vehicle; +p < 0.05, 
vs. GSC-EXscon or GSC-EXssc; #p < 0.05, vs. GSC-EXsmiR-21 or GSC-EXsmiR-21+siRNAsc.  Data are expressed as mean ± SEM; n = 4/group.
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we directly cultured ECs in the presence of different types 
of GSC-EXs. Our results demonstrated that the PKH26 
labeled GSC-EXs were up-taken by ECs after co-culture 
(Figure 4). More importantly, we found that the GSC-
EXsmiR-21 can remarkably increase miR-21 level in ECs, 
suggesting that the GSC-EXsmiR-21 can delivery miR-21 
to ECs. Meanwhile, we found the level of VEGF in the 
culture medium of ECs was significantly elevated after 
the incubation with GSC-EXsmiR-21(Figure 4). The elevated 
level of miR-21 could be attributed to the directly delivery 
of VEGF via GSC-EXsmiR-21 and/or through the secretion 
of VEGF of ECs enhanced by GSC-EXsmiR-21. This data 
was supported by a previous report showing that exosomal 
miR-21 can activate STAT3 to increase VEGF secretion of 
human umbilical vein ECs [28]. 
For further assess whether GSC-EXs miR-21 harboring 
high levels of miR-21 and VEGF can promote the 
angiogenesis response, ECs were evaluated by using tube 
Figure 6: GSC-EXsmiR-21 had better effect than GSC-EXscon and GSC-EXssc on activating the VEGF/VEGFR2 
signal in ECs. (A) representative bands showing the expressions of VEGFR2 and its phosphorylation in ECs; (B) summarized data 
showing the ratio of p-Flk1/VEGFR2. * p < 0.05, vs. vehicle; +p < 0.05, vs. GSC-EXscon or GSC-Exssc.  Data are expressed as mean ± SEM; 
n = 4/group. 
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formation assay. The results revealed that GSC-EXscon 
and GSC-EXssc alone can promote tube formation on 
the matrigel, and GSC-EXsmiR-21 exhibited the best effect 
(Figure 5). These data were supported by a previous report 
showing that the extracellular vesicles derived from U251 
cells had the ability to stimulate EC activities [35]. The 
proved pro-angiogenic ability of GSC-EXs could be 
explained, at least partially, was attributed to their miR-
21 and VEGF contents. VEGF is well known as a pro-
angiogenic factor [36]. Its release by tumor cells as a 
component of membrane vesicles has been highlighted 
[37]. In order to verify the role of VEGF in promoting 
EC angiogenesis, we knocked down VEGF by using 
siRNAVEGF and observed that a significantly less amount 
of tubes were formed by ECs, reflecting that VEGF is 
involved in GSC-EXs mediated endothelial angiogenesis.
It is believed that VEGFR2 is responsible for 
most downstream angiogenic effects of VEGF including 
changes in vascular permeability, endothelial proliferation, 
invasion, migration, and survival [38]. Binding of VEGF to 
VEGFR2 can activate downstream survival and migration 
pathways involving PI3-kinase/Akt and focal adhesion 
kinase [39]. In the present study, our results indicate that 
the ratio of p-Flk1/VEGFR2 was significantly elevated in 
ECs co-cultured with the GSC-EXsmiR-21 (Figure 6). These 
data reflect that the VEGF/VEGFR2 signal was activated 
in ECs after the incubation with GSC-EXs.
Altogether, our results indicate that GSC-EXs 
fully equipped for angiogenesis stimulation through their 
carried miR-21 and pro-angiogenic growth factor VEGF to 
activate the angiogenic ability of ECs. These data suggest 
an important role for GSCs in tumor angiogenesis and in 
elucidation of the mechanistic basis which will benefit the 
development of novel therapeutic strategies. However, 
in vivo research should be done for further studying the 
effects of GSC-EXs in tumor metastasis. 
MATERIALS AND METHODS
Cell culture 
Human GBM cell line U-251 cells were purchased 
from ATCC (Manassas, VA, USA). The cells were cultured 
with DMEM medium supplemented with 4.5g/L glucose, 
2 mM L-glutamine and 10% fetal bovine serum (FBS) 
according to the manufacture’s instruction. Medium was 
replaced twice a week. 
Human brain ECs were purchased from Cell 
systems (Kirkland, WA, USA) and cultured according to 
the manufacturer’s protocol. In brief, ECs were cultured 
in CSC complete medium containing 10% serum, 2% 
human recombinant growth factors, and 0.2% antibiotic 
solution under standard cell culture conditions (5% 
CO2, 37°C). All medium and supplement reagents were 
purchased from Cell Systems. Medium was changed 
twice a week.
Purification of GSCs with CD133-conjugated 
microbeads from glioblastoma cells by using 
magnetic activated cell sorting 
CD133 has been used to enrich the putative 
cancer stem cells [25, 26]. In this study, the anti-CD133-
conjugated microbeads were applied to isolate GSCs 
from U-251 cells by using magnetic activated cell sorting 
(MACS) as previously reported with slight modification 
[40]. In brief, U-251 MG cells were incubated with 
anti-CD133-conjugated microbeads antibody (10 µl 
anti-CD133 microbeads per 107 U251 cells) in 100 µl 
reaction volume for 20 mins in the refrigerator. Then, the 
CD133+ cells were collected by using a magnet separator 
(DynaMag-2 magnet; Thermo scientific). The purity of 
GSCs was confirmed by flow cytometry analysis. The 
purified GSCs were expanded in DMEM/F12 medium 
containing 2% B27 (without retinoic acid), EGF (20 ng/
ml), FGF-2 (20 ng/ml), heparin (5 µg/ml), glutamine (2 
mM) and 1% antibiotics. 
For flow cytometry analysis, the purified GSCs 
and U-251 MG cells were washed with PBS twice, and 
then incubated with FITC-conjugated CD133 (5 µl/1x106 
cells, Miltenyi Biotec), or isotype control antibody (FITC-
conjugated IgG, 20 µl/1x106 cells, BD biosciences) for 
30 mins in the dark. After incubation, the samples were 
analyzed under flow cytometry (BD C6 flow cytometer). 
10,000 events were collected for analysis. The experiment 
was repeated three times.
Cell transfection
The purified GSCs were expanded and used 
for miR-21 mimics transfection to overexpress miR-
21 [41]. Briefly, the GSCs were cultured to 60–70% 
confluence, and transfected with miR-21 mimics or 
the SC of miR-21 (40 nM, Thermo Fisher Scientific, 
Waltham, MA) by using lipofectamine 2000 (Invitrogen, 
Carlsbad, CA) for 48 hrs according to the manufacturer’s 
instruction. The sequences of miR-21 mimics were: sense 
5′-UAGCUUAUCAGACUGAUGUUGA-3′; antisense 
5′-AACAUCAGUCUGAUAAGCUAUU-3′. GSCs 
transfected with miR21 SC or mimics or inhibitors were 
denoted as GSCssc or GSCsmiR-21, respectively. GSCs 
cultured in complete culture medium served as control 
(GSCscon). The levels of miR-21 and protein in GSCs were 
extracted after transfection, respectively. The experiment 
was repeated four times. The three types of GSCs were 
used for producing corresponding EXs.
Preparation and collection of EXs released from 
GSCs
The protocol for collecting EXs from serum-
free conditionl medium (CM) has been reported in our 
previous study [42]. Briefly, GSCscon, GSCssc, GSCsmiR-21 
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ko or GSCsmiR-21 were cultured in CM composed of 
DMEM medium supplemented with 4.5g/L glucose, 2 
mM L-glutamine to release EXs which were denoted as 
GSC-EXscon, GSC-EXssc or GSC-EXsmiR-21. After 24 hrs, 
the respective CM was collected and centrifuged at 300g, 
15 mins to remove dead cells. The supernatants were 
centrifuged at 2000 g, 30 mins to remove cell debris, 
followed by centrifugation at 20,000 g, 70 mins, and 
ultracentrifugation at 170,000 g, 90 mins to pellet EXs. The 
pelleted EXs were resuspended with phosphate-buffered 
saline (PBS) and aliquoted for nanoparticle tracking 
analysis (NTA) and co-culture experiments. PBS was 
filtered through 20 nm-filter (Whatman, Pittsburgh, PA).
Nanoparticle tracking analysis of GSC-EXs
The NanoSight NS300 (Malvern Instruments, 
Malvern, UK) was used to analyze the size, concentration 
and CD63 expreesion of EXs at light-scatter or 
fluorescence-scatter mode as we previously reported 
[42]. Briefly, for size and concentration detection, the 
collected EXs were resuspended with 700 ul filtered 
PBS and analyzed under light-scatter mode of NTA. For 
detection of CD63 expression in EXs, the collected EXs 
were incubated with CD63-conjugated microbeads (10 
ul; Miltenyi Biotec) in a 100 µl reaction volume for 2 
hrs. Then, a magnet module (DynaMag-2 magnet; Life 
technology) was applied to separate CD63+ EXs from the 
total EX suspension. After an overnight magnet separation, 
the CD63+ EXs were resuspended with 100 µl filtered PBS 
and incubated with rabbit anti-goat IgG conjugated with 
Q-dot 655 (1:350; Life Technologies) for 90 mins at RT. 
All samples were analyzed under fluorescence-scatter 
mode of NTA. Three videos of typically 30 seconds 
duration were taken, with a frame rate of 30 frames per 
second. Data was analyzed by NTA 3.0 software (Malvern 
Instruments, Malvern, UK) on a frame-by-frame basis. 
The experiment was repeated four times.
Co-culture of GSC-EXs with ECs
In order to determine whether GSC-EXs can be up-
taken by ECs, the three types of GSC-EXs were labeled 
with PKH 26 and co-cultured with ECs [16]. In brief, 
GSC-EXs were labeled with PKH 26 (2 × 10−6 M, Sigma-
Aldrich) for 5 mins at 37 °C, followed by wash with 1 x 
PBS and ultracentrifuged at 170,000g for 90 mins. After 
that, GSC-EXs (50 µg) were resuspended and added to 
the culture medium (1 ml) of ECs for co-culture. After 
24 hrs, ECs were washed with PBS for twice, and the 
nuclei of ECs were stained with DAPI (1 μg/ml, Wako 
Pure Chemical Industries Ltd) for 2 mins. Incorporation 
of GSC-EXs into ECs was observed by fluorescence 
microscopy (EVOS; Thermo Fisher Scientific). The 
level of cellular fluorescence intensity was analyzed by 
Image J (NIH) according to the instruction and a previous 
report [43]. Briefly, the cell of interest and a region next 
to the cell of interest that has no fluoresce (considered 
as background) were selected. The area, integrated 
density and mean gray value were measured. The cellular 
fluorescence was calculated as: cellular fluorescence = 
integrated density - (area of the selected cell x fluorescence 
of background readings). The fluorescence intensities of 
one hundred cells in five random fields in each group were 
averaged. The experiment was repeated four times. 
To further elucidate whether GSC-EXs can alter 
the function of ECs, ECs were divided into five groups 
and co-cultured with: vehicle (co-culture medium 
only), GSC-EXscon, GSC-EXssc, GSC-EXsmiR-21 ko, GSC-
EXsmiR-21. The work concentration of GSC-EXs (50 μg/
ml) was determined based on our previous study [16]. 
Some ECs were pre-transfected with VEGF siRNA 
(siRNAVEGF; 50 nM; Qiagen) using oligofectmanine 
transfection reagent (Invitrogen, Carlsbad, CA) for 48 hrs 
to knock out the endogenous VEGF, and then co-cultured 
with GSC-EXsmiR-21. Scrambled siRNA (siRNAsc; 50 nM; 
Qiagen) was used as an experimental control. After 24 
hrs, the culture medium of ECs were collected for VEGF 
analysis. The miR-21 level in ECs was analyzed by 
quantitative RT-PCR analysis. ECs were used for tube 
formation and migration assays. The experiment was 
repeated four times.
Quantitative RT-PCR analysis
After transfection, cells were washed with 1xPBS. 
The total mRNA from GSCs was extracted using and 
lysed in Trizol (Thermo Fisher Scientific, Waltham, 
MA). The miRs from GSCs, and from ECs co-cultured 
with different types of GSC-EXs were extracted using 
mirVana miRNA Isolation kit (Qiagen). For detecting 
miR-21 level, reverse transcription (RT) reactions 
were performed by using mirVana qRT-PCR miRNA 
Detection Kit and hsa-miR-21 qRT-PCR primer set 
from Ambion. The forward primer of miR-21 was: 
5′-TTTTGTTTTGCTTGGGAGGA-3′, the reverse primer 
of miR-21 was: 5′-AGCAGACAGTCAGGCAGGAT-3′. 
For measuring the mRNA level of VEGF in GSCs, 
RT was performed by using the first strand cDNA 
synthesis kit (Qiagen) according to manufacturer’s 
instruction. The forward primer of VEGF was, 
5′-CGAGGGCCTGGAGTGTG-3′, the reverse primer 
of VEGF was, 5′-CCGCATAATCTGCATGGTGAT-3′. 
The expression of U6 was used as endogenous control 
for each sample. The forward primer of U6 was: 
5′-CTCGCTTCGGCAGCACA-3′, the reverse primer of 
U6 was: 5′-AACGCTTCACGAATTTGCGT-3′. Relative 
expression level of each gene was normalized to U6 and 
calculated using the 2-ΔΔCT method. The experiment was 
repeated four times.
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Enzyme-linked immunosorbent assay
The level of VEGF in the culture medium of ECs co-
cultured with the three types of GSC-EXs were measured 
by enzyme-linked immunosorbent assay (ELISA) 
according to the manufacturer’s instructions (R&D 
Systems). The concentration of VEGF was calculated as 
pg/ml of culture medium. The experiment was repeated 
four times.
Migration and tube formation assay for ECs
The migration assay was carried out by using 
the Boyden chamber (Chemicon, Rosemont, IL) as 
we previously reported with slight modification [44]. 
In brief, ECs (2 x 104 cells) were seeded into the upper 
compartment of the boyden chamber. After 24 hrs, the ECs 
which migrated across the membrane were counted under 
an inverted light microscope. Ten random microscopic 
fields were assessed in each well. The average number of 
cells per field was determined.
The tube formation assay was conducted by using 
in vitro angiogenesis assay kit (Chemicon). First, the 
ECMatrix solution were thawed and mixed with the 
ECMatrix diluent. Then, the ECMatrix mixture were 
placed in a 96-well tissue culture plate at 37ºC for 1 hr to 
allow the matrix solution to solidify. ECs (1 × 104 cells/
well) were seeded onto the solidified matrix and incubated 
at regular cell culture conditions (5% CO2, 37°C). After 
24 hr post-seeding, 2 µg/ml calcein (Fisher scientific) 
was directly added to the culture well and incubated for 
20 mins prior to imaging under an inverted fluorescence 
microscope. Tubes were defined as a tube structure 
exhibiting a length 4 times of its width [45]. Five random 
microscopic fields were assessed in each well. The average 
number of tubes per field was determined. 
Western blot analysis
After 24 hr co-culture, proteins of ECs in different 
groups were extracted with cell lysis buffer (Thermo 
Fisher scientific) supplemented with complete mini 
protease inhibitor tablet (Roche). Then, the protein 
lysates were electrophoresed through SDS-PAGE gel 
and transferred onto PVDF membranes. The membranes 
were blocked with 5% non-fat milk for 1 hr at room 
temperature, and incubated with primary antibody against 
VEGFR2 (1:1000; Santa Cruz), p-Flk1 (1:1000; Santa 
Cruz) or β-actin (1:4000; Sigma) at 4ºC overnight. On 
the next day, membranes were washed and incubated 
with horseradish-peroxidase-conjugated anti-rabbit or 
anti-mouse IgG (1:40000; Jackson Immuno Research 
Lab) for 1 hr at room temperature. Blots were developed 
with enhanced chemiluminescence developing solutions 
and images were quantified under ImageJ software. The 
experiment was repeated four times.
Statistical analysis
Data is expressed as mean ± SEM. Two group 
comparison was analyzed by Student’s t test. Multiple 
comparisons were analyzed by one- or two-way 
ANOVA followed by LSD post-hoc test. SPSS 17.0 
statistical software was used for analyzing the data. For 
all measurements, a p < 0.05 was considered statistic 
significant.
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